vs
ACCESS Newswire Inc.（ACCS）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是ACCESS Newswire Inc.的1.6倍（$9.1M vs $5.8M），ACCESS Newswire Inc.净利率更高（-9.9% vs -60.3%，领先50.4%），ACCESS Newswire Inc.同比增速更快（-0.5% vs -49.9%），过去两年ACCESS Newswire Inc.的营收复合增速更高（2.0% vs -6.7%）
ACCESS通讯社是一家新闻通稿分发服务商，总部位于芝加哥，1954年成立，最初通过电传设备为企业向新闻机构电子传输新闻稿，创始人赫伯特·穆舍勒曾在曼哈顿家中运营该业务长达15年，公司几经转手后，于2015年被Cision集团宣布收购。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
ACCS vs PLX — 直观对比
营收规模更大
PLX
是对方的1.6倍
$5.8M
营收增速更快
ACCS
高出49.5%
-49.9%
净利率更高
ACCS
高出50.4%
-60.3%
两年增速更快
ACCS
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.8M | $9.1M |
| 净利润 | $-576.0K | $-5.5M |
| 毛利率 | 77.4% | 49.4% |
| 营业利润率 | -13.1% | -51.1% |
| 净利率 | -9.9% | -60.3% |
| 营收同比 | -0.5% | -49.9% |
| 净利润同比 | 94.4% | -184.8% |
| 每股收益（稀释后） | $-0.16 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACCSPLX
| Q4 25 | $5.8M | $9.1M | ||
| Q3 25 | $5.7M | $17.9M | ||
| Q2 25 | $5.6M | $15.7M | ||
| Q1 25 | $5.5M | $10.1M | ||
| Q4 24 | $5.8M | $18.2M | ||
| Q3 24 | $5.6M | $18.0M | ||
| Q2 24 | $6.0M | $13.5M | ||
| Q1 24 | $5.6M | — |
净利润ACCSPLX
| Q4 25 | $-576.0K | $-5.5M | ||
| Q3 25 | $-45.0K | $2.4M | ||
| Q2 25 | $-475.0K | $164.0K | ||
| Q1 25 | $5.4M | $-3.6M | ||
| Q4 24 | $-10.2M | $6.5M | ||
| Q3 24 | $-466.0K | $3.2M | ||
| Q2 24 | $7.0K | $-2.2M | ||
| Q1 24 | $-139.0K | — |
毛利率ACCSPLX
| Q4 25 | 77.4% | 49.4% | ||
| Q3 25 | 74.6% | 53.4% | ||
| Q2 25 | 76.2% | 62.5% | ||
| Q1 25 | 78.0% | 19.1% | ||
| Q4 24 | 75.2% | 78.7% | ||
| Q3 24 | 75.0% | 53.4% | ||
| Q2 24 | 77.2% | 29.8% | ||
| Q1 24 | 75.1% | — |
营业利润率ACCSPLX
| Q4 25 | -13.1% | -51.1% | ||
| Q3 25 | -3.2% | 11.9% | ||
| Q2 25 | -4.4% | 7.5% | ||
| Q1 25 | -12.4% | -41.0% | ||
| Q4 24 | -245.8% | 39.6% | ||
| Q3 24 | -10.7% | 22.2% | ||
| Q2 24 | -8.8% | -18.0% | ||
| Q1 24 | -15.5% | — |
净利率ACCSPLX
| Q4 25 | -9.9% | -60.3% | ||
| Q3 25 | -0.8% | 13.2% | ||
| Q2 25 | -8.5% | 1.0% | ||
| Q1 25 | 98.4% | -35.8% | ||
| Q4 24 | -175.0% | 35.6% | ||
| Q3 24 | -8.3% | 18.0% | ||
| Q2 24 | 0.1% | -16.4% | ||
| Q1 24 | -2.5% | — |
每股收益（稀释后）ACCSPLX
| Q4 25 | $-0.16 | $-0.06 | ||
| Q3 25 | $-0.01 | $0.03 | ||
| Q2 25 | $-0.12 | $0.00 | ||
| Q1 25 | $1.40 | $-0.05 | ||
| Q4 24 | $-2.66 | $0.10 | ||
| Q3 24 | $-0.12 | $0.03 | ||
| Q2 24 | $0.00 | $-0.03 | ||
| Q1 24 | $-0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $30.3M | $48.2M |
| 总资产 | $42.0M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACCSPLX
| Q4 25 | $3.0M | $14.7M | ||
| Q3 25 | $3.3M | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | $4.1M | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q1 24 | — | — |
股东权益ACCSPLX
| Q4 25 | $30.3M | $48.2M | ||
| Q3 25 | $30.8M | $52.9M | ||
| Q2 25 | $30.7M | $49.9M | ||
| Q1 25 | $30.9M | $45.2M | ||
| Q4 24 | $25.2M | $43.2M | ||
| Q3 24 | $35.3M | $32.4M | ||
| Q2 24 | $35.4M | $28.6M | ||
| Q1 24 | $35.2M | — |
总资产ACCSPLX
| Q4 25 | $42.0M | $82.3M | ||
| Q3 25 | $44.0M | $82.3M | ||
| Q2 25 | $45.6M | $78.5M | ||
| Q1 25 | $47.3M | $73.9M | ||
| Q4 24 | $50.6M | $73.4M | ||
| Q3 24 | $61.7M | $61.6M | ||
| Q2 24 | $62.8M | $91.5M | ||
| Q1 24 | $64.4M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $258.0K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | 0.0% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流ACCSPLX
| Q4 25 | $258.0K | $2.0M | ||
| Q3 25 | $-582.0K | $-3.7M | ||
| Q2 25 | $135.0K | $-5.2M | ||
| Q1 25 | $747.0K | $-5.1M | ||
| Q4 24 | $866.0K | $4.0M | ||
| Q3 24 | $1.5M | $4.1M | ||
| Q2 24 | $-190.0K | $-3.6M | ||
| Q1 24 | $986.0K | — |
自由现金流ACCSPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | $-590.0K | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | $735.0K | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | $1.5M | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | $970.0K | — |
自由现金流率ACCSPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | -10.3% | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | 13.4% | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | 26.5% | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | 17.4% | — |
资本支出强度ACCSPLX
| Q4 25 | 0.0% | 4.4% | ||
| Q3 25 | 0.1% | 2.8% | ||
| Q2 25 | 0.0% | 2.8% | ||
| Q1 25 | 0.2% | 3.0% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.1% | 0.5% | ||
| Q2 24 | 0.0% | 1.3% | ||
| Q1 24 | 0.3% | — |
现金转化率ACCSPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | -27.14× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACCS
| Cost To Deliver Products | $3.1M | 54% |
| Employee Costs | $1.7M | 29% |
| Other | $1.0M | 17% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
